Theranostics in nuclear medicine practice

about

Innovative Technologies Changing Cancer Treatment.The Global Perspective of Pharmacovigilance in Nuclear Medicine Practice

P2860

Q55479035-D816EE36-24F9-42AF-B94A-A406059B5D29 Q58593332-F99168EF-ADEB-4751-A445-A469F0B58870

P2860

Theranostics in nuclear medicine practice

Item

http://www.wikidata.org/entity/Q42373162

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Theranostics in nuclear medicine practice

@en

Theranostics in nuclear medicine practice

@nl

type

Item

label

Theranostics in nuclear medicine practice

@en

Theranostics in nuclear medicine practice

@nl

prefLabel

Theranostics in nuclear medicine practice

@en

Theranostics in nuclear medicine practice

@nl

P1476

Theranostics in nuclear medicine practice

@en

P2093

Elisabeth Eppard

http://www.w3.org/2001/XMLSchema#string

Georg Feldmann

http://www.w3.org/2001/XMLSchema#string

Maria Gonzalez-Carmona

http://www.w3.org/2001/XMLSchema#string

Markus Essler

http://www.w3.org/2001/XMLSchema#string

Ralph A Bundschuh

http://www.w3.org/2001/XMLSchema#string

Stefan Kürpig

http://www.w3.org/2001/XMLSchema#string

P2860

Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

A comparative study of 188Re-HEDP, 186Re-HEDP, 153Sm-EDTMP and 89Sr in the treatment of painful skeletal metastases.

German Multicenter Study Investigating 177Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients.

Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors.

The mechanism of action of thyroid hormones.

Does chemotherapy have a role as palliative therapy for unfit or elderly patients with non-small-cell lung cancer?

The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer.

Patient-specific dosimetry using pretherapy [¹²⁴I]m-iodobenzylguanidine ([¹²⁴I]mIBG) dynamic PET/CT imaging before [¹³¹I]mIBG targeted radionuclide therapy for neuroblastoma.

Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer.

P304

4821-4828

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OTT.S140671

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hojjat Ahmadzadehfar

Stefan Schönberger

Anna Yordanova

P577

2017-10-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29042793

http://www.w3.org/2001/XMLSchema#string

P932

5633297

http://www.w3.org/2001/XMLSchema#string

Theranostics in nuclear medicine practice

about

P2860

P2860

Theranostics in nuclear medicine practice

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P932